Drugs / Sufentanil
Sufentanil
also known as
sufentanyl · Sufentanil Citrate · ARX-F01 · DSUVIA · sufentanil injection · Sufentanil NanoTab · Brand name:Sufenta · Dzuveo · +14 more
Other / unclassified targets OPRM1 via activation
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Zalviso | — | 2015-09-18 | europa.eu ↗ |
| Label expansion | US (FDA) | SUFENTA PRESERVATIVE FREE | — | 1993-03-19 | fda.gov ↗ |
| Approved | US (FDA) | SUFENTA PRESERVATIVE FREE | — | 1984-05-04 | fda.gov ↗ |
Trials 112 · started per year
today
US approved 1984
EU approved 2015
1
2
1
5
3
6
1
9
4
7
6
5
5
6
8
9
3
5
7
6
7
5
1
1984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT07603596 | May 2026 → Apr 2028 expected | delirium, digestive system neoplasm | Qianfoshan Hospital | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT02082236 | May 2014 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 1 | NCT01761565 | Jan → Feb 2013 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 1 | NCT01721070 | Nov → Dec 2012 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 1 | NCT01639729 | Jul 2012 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT04959812 | Mar 2022 → Sep 2023 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 1/2 | NCT01012999 | Nov 2009 → Mar 2011 | — | University of Utah | Terminated | No outcome recorded |
| Phase 211 trials | ||||||
| Phase 2 | NCT06968546 | Feb 2026 → Mar 2028 expected | disease of bone structure | Fondation Lenval | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04897750 | Aug 2021 → May 2022 | pain agnosia | Cessatech A/S | Completed | No outcome recorded |
| Phase 2 | NCT02962830 | Apr 2017 → May 2024 | — | University Hospital, Lille | Completed | No outcome recorded |
| Phase 2 | NCT01710345 | Oct 2012 → Feb 2013 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 2 | NCT01047241 | Apr 2010 → Feb 2013 | — | Danish University of Pharmaceutical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00943566 | Jan → Dec 2010 | chronic pain syndrome | Labtec GmbH | Withdrawn | No outcome recorded |
| Phase 2 | NCT00833040 | Apr 2009 → Mar 2010 | cancer | Talphera, Inc | Completed | No outcome recorded |
| Phase 2 | NCT00859313 | Apr → Aug 2009 | neuropathy, painful | Talphera, Inc | Completed | No outcome recorded |
| Phase 2 | NCT00718081 | Aug 2008 → Mar 2009 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 2 | NCT00612534 | Mar → Oct 2008 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 2 | NCT02430090 | Nov 2006 → Mar 2007 | — | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT06364072 | May 2024 → May 2025 | — | Cessatech A/S | Completed | No outcome recorded |
| Phase 2/3 | NCT02334150 | Jun 2013 → Jun 2014 | dystocia | Nanjing Maternity and Child Health Care Hospital | Completed | No outcome recorded |
| Phase 321 trials | ||||||
| Phase 3 | NCT06917651 | Apr 2025 → Apr 2027 expected | — | University Hospital, Clermont-Ferrand | Recruiting | No outcome recorded |
| Phase 3 | NCT06181695 | May 2024 → May 2026 overdue | sickle cell disease | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05288348 | Aug 2022 → Jan 2024 | — | Frank Guyette | Completed | No outcome recorded |
| Phase 3 | NCT05196256 | Jun 2022 → Jun 2023 | obstetric disorder | Brugmann University Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04076748 | Jul 2021 → Jul 2024 | sickle cell disease | University Hospital, Bordeaux | Terminated | No outcome recorded |
| Phase 3 | NCT03639389 | Jan 2019 → Mar 2022 | — | Karolinska Institutet | Completed | No outcome recorded |
| Phase 3 | NCT05576675 | May 2018 → Mar 2022 | — | Xijing Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02662764 | Sep 2016 → Apr 2017 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02662556 | Mar → Jun 2016 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02447848 | Oct 2015 → Jun 2016 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02356588 | Feb → Jun 2015 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02868944 | Aug 2014 → Jan 2017 | — | Reims University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02264834 | Jul 2014 → Mar 2018 | — | Dr Madeleine Wilwerth | Completed | No outcome recorded |
| Phase 3 | NCT01660763 | Aug 2012 → Apr 2013 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT01539538 | Apr → Dec 2012 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT01539642 | Feb 2012 → Jan 2013 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT01367418 | Sep 2010 → Mar 2012 | prostate cancer | Örebro University, Sweden | Completed | No outcome recorded |
| Phase 3 | NCT01082744 | Mar 2010 → Sep 2014 | neuropathy, painful | Hospices Civils de Lyon | Completed | No outcome recorded |
| Phase 3 | NCT01025102 | Jan 2010 → Nov 2012 | — | Bent Gymoese Jorgensen | Completed | No outcome recorded |
| Phase 3 | NCT00656773 | Jan → Sep 2008 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 3 | NCT00389883 | Nov 2006 → Jan 2010 | supratentorial cancer | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 429 trials | ||||||
| Phase 4 | NCT07624006 | Jan 2027 → Feb 2030 expected | — | University Hospital, Strasbourg, France | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07597564 | Jun 2026 → May 2027 expected | — | Fujian Provincial Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07026162 | Jul 2025 → Feb 2026 | — | YanYing Xiao | Completed | No outcome recorded |
| Phase 4 | NCT06784999 | Jan 2025 → Nov 2027 expected | — | Indiana University | Recruiting | No outcome recorded |
| Phase 4 | NCT05957653 | Oct 2023 → Sep 2025 | prostate cancer | RenJi Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT06439368 | Jan 2023 → Dec 2024 | — | Yangtze River Pharmaceutical Group Co., Ltd. | Unknown | No outcome recorded |
| Phase 4 | NCT04716413 | Sep 2021 → Nov 2022 | — | Montefiore Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT04263909 | Dec 2020 → Apr 2022 | substance-related disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04387136 | Oct 2020 → Feb 2021 | — | University of Minnesota | Completed | No outcome recorded |
| Phase 4 | NCT04226495 | Oct 2020 → Oct 2021 | — | University of Nebraska | Completed | No outcome recorded |
| Phase 4 | NCT04443946 | Jun → Aug 2020 | — | China International Neuroscience Institution | Completed | No outcome recorded |
| Phase 4 | NCT04432428 | May 2020 → Aug 2021 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 4 | NCT04396587 | May 2020 → Jan 2023 | substance-related disorder | Peking University People's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04137198 | Jan 2020 → Jul 2025 | — | Centre Hospitalier Universitaire Saint Pierre | Unknown | No outcome recorded |
| Phase 4 | NCT04177862 | Dec 2019 → Jan 2020 | — | University of Minnesota | Completed | No outcome recorded |
| Phase 4 | NCT04111328 | Oct 2019 → Sep 2020 | — | Jun Wang | Completed | No outcome recorded |
| Phase 4 | NCT05259098 | Oct 2019 → Jun 2020 | chronic pain syndrome | Hospital Central do Funchal | Completed | No outcome recorded |
| Phase 4 | NCT03901716 | Jan → Mar 2019 | — | Guangzhou Institute of Respiratory Disease | Completed | No outcome recorded |
| Phase 4 | NCT03386630 | Mar 2018 → Jun 2019 | — | Fundación Pública Andaluza Progreso y Salud | Completed | No outcome recorded |
| Phase 4 | NCT03135795 | Feb → May 2017 | — | Huazhong University of Science and Technology | Unknown | No outcome recorded |
| Phase 4 | NCT03224039 | Jan 2017 → Jan 2019 | — | The Brooklyn Hospital Center | Unknown | No outcome recorded |
| Phase 4 | NCT02503826 | Jan → Dec 2015 | — | Second Affiliated Hospital of Xi'an Jiaotong University | Unknown | No outcome recorded |
| Phase 4 | NCT02205580 | Sep → Dec 2014 | adenoid hypertrophy, sleep apnea syndrome, tonsillitis | Jin Ni | Unknown | No outcome recorded |
| Phase 4 | NCT01954368 | Jan 2014 → Mar 2016 | — | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
| Phase 4 | NCT02095366 | Aug 2013 → Apr 2016 | — | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 4 | NCT01777100 | Jul 2012 → Oct 2014 | — | University of Sao Paulo | Completed | No outcome recorded |
| Phase 4 | NCT01356732 | Jan → Oct 2010 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 4 | NCT00577200 | Jan 2008 → Nov 2026 expected | — | Rush University Medical Center | Active not recruiting | No outcome recorded |
| Phase 4 | NCT00421720 | Jan 2007 → ? | — | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase not applicable42 trials | ||||||
| — | NCT07650812 | Jul 2026 → Dec 2027 expected | bowel dysfunction | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07651722 | Jun → Sep 2026 expected | paralytic ileus | Tianjin First Central Hospital | Recruiting | No outcome recorded |
| — | NCT07089173 | Aug 2025 → Jul 2026 overdue | — | Peking University Shenzhen Hospital | Recruiting | No outcome recorded |
| — | NCT07401641 | Jun 2025 → Jun 2026 overdue | oral cavity cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Recruiting | No outcome recorded |
| — | NCT06990893 | Jun 2025 → Oct 2026 expected | — | Anqing Municipal Hospital | Recruiting | No outcome recorded |
| — | NCT06808841 | Feb → May 2025 overdue | — | Second Hospital of Shanxi Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06015165 | Sep 2024 → Jun 2025 overdue | — | China-Japan Friendship Hospital | Recruiting | No outcome recorded |
| — | NCT06414018 | May → Dec 2024 | — | Tongji Hospital | Completed | No outcome recorded |
| — | NCT06260046 | Mar 2024 → Jan 2025 overdue | — | Seoul National University Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06658990 | Feb → Jun 2024 | — | Northern Jiangsu People's Hospital | Completed | No outcome recorded |
| — | NCT06091904 | Nov 2023 → Nov 2025 overdue | — | Seoul National University Hospital | Recruiting | No outcome recorded |
| — | NCT05863455 | May 2023 → Oct 2024 | — | Affiliated Hospital of Jiaxing University | Completed | No outcome recorded |
| — | NCT05384665 | May → Oct 2023 | — | Centre Hospitalier Sud Francilien | Terminated | No outcome recorded |
| — | NCT05785234 | Apr 2023 → Mar 2025 | gastric neoplasm | Yonsei University | Unknown | No outcome recorded |
| — | NCT05672212 | Jan 2023 → Jan 2025 | — | Seoul National University Hospital | Unknown | No outcome recorded |
| — | NCT05497492 | Nov 2022 → Dec 2023 | — | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT06000137 | Feb 2022 → Jan 2023 | — | Eye & ENT Hospital of Fudan University | Completed | No outcome recorded |
| — | NCT04446715 | Oct 2020 → Aug 2021 | — | Makassed General Hospital | Unknown | No outcome recorded |
| — | NCT04067648 | Jul 2020 → Dec 2022 | — | Tongji Hospital | Completed | No outcome recorded |
| — | NCT03868111 | Nov 2019 → Jan 2020 | — | Kangbuk Samsung Hospital | Completed | No outcome recorded |
| — | NCT04121416 | Apr → Aug 2019 | cardiovascular disorder | Shengjing Hospital | Completed | No outcome recorded |
| — | NCT03864016 | Mar → Oct 2019 | — | Centre Hospitalier Universitaire Dijon | Completed | No outcome recorded |
| — | NCT03598192 | Aug → Sep 2018 | liver disorder | Gia Dinh People Hospital | Completed | No outcome recorded |
| — | NCT03622047 | Aug 2018 → Aug 2020 | — | Fudan University | Unknown | No outcome recorded |
| — | NCT03381495 | May → Sep 2018 | mental disorder | Deng Dongrui | Unknown | No outcome recorded |
| — | NCT04048070 | May → Oct 2018 | chronic rhinosinusitis | Beijing Tongren Hospital | Completed | No outcome recorded |
| — | NCT04448457 | Sep 2017 → Jul 2018 | — | Centre Hospitalier Universitaire de Tivoli | Completed | No outcome recorded |
| — | NCT03171610 | Jun 2017 → Jan 2018 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02920489 | Aug 2016 → Jun 2017 | — | Peking University First Hospital | Completed | No outcome recorded |
| — | NCT05596071 | Jun 2016 → Jul 2020 | delirium | Zhejiang Cancer Hospital | Completed | No outcome recorded |
| — | NCT02604797 | Jan 2016 → Jan 2017 | — | Fudan University | Unknown | No outcome recorded |
| — | NCT02595333 | Nov 2015 → Aug 2017 | — | Fudan University | Unknown | No outcome recorded |
| — | NCT02490540 | Jun → Oct 2015 | — | University Hospital Hradec Kralove | Completed | No outcome recorded |
| — | NCT02505880 | Jun 2015 → Jan 2018 | — | University Hospital, Montpellier | Completed | No outcome recorded |
| — | NCT02710877 | Dec 2014 → Dec 2017 | — | University of Modena and Reggio Emilia | Terminated | No outcome recorded |
| — | NCT02488291 | Apr 2014 → Jun 2015 | — | Fudan University | Completed | No outcome recorded |
| — | NCT01856166 | Jun 2013 → Dec 2015 | pregnancy disorder | University Hospital, Montpellier | Completed | No outcome recorded |
| — | NCT02831101 | Feb 2012 → Nov 2015 | — | University Hospital, Geneva | Completed | No outcome recorded |
| — | NCT01917045 | Jan 2012 → Mar 2013 | — | Peking University First Hospital | Completed | No outcome recorded |
| — | NCT01505283 | Dec 2011 → Jul 2015 | — | Hopital Foch | Terminated | No outcome recorded |
| — | NCT01086956 | Sep 2008 → Dec 2009 | prostate cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT00434382 | Oct 2002 → Dec 2003 | — | Ludwig-Maximilians - University of Munich | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 191 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT06570538 Comparator | Sep 2024 → May 2025 overdue | — | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT03763084 Comparator | Feb 2019 → Feb 2020 | delirium, paracetamol poisoning | Xiangya Hospital of Central South University | Unknown | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT05742256 Comparator | Mar 2023 → Jul 2024 | — | Qianfoshan Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT04807335 Comparator | Mar → Jun 2021 | — | Cessatech A/S | Completed | No outcome recorded |
| Phase 210 trials | ||||||
| Phase 2 | NCT07510217 Comparator | Aug 2024 → Dec 2025 | — | Tanta University | Completed | No outcome recorded |
| Phase 2 | NCT06036797 Comparator | Sep → Oct 2023 | — | Maternal and Child Health Hospital of Hubei Province | Unknown | No outcome recorded |
| Phase 2 | NCT05901441 Comparator | Jun 2022 → May 2023 | — | Maternal and Child Health Hospital of Hubei Province | Completed | No outcome recorded |
| Phase 2 | NCT03433976 Background | May 2018 → May 2020 | — | University Hospital, Montpellier | Unknown | No outcome recorded |
| Phase 2 | NCT02705872 Comparator | Mar 2016 → Mar 2018 | — | Brugmann University Hospital | Withdrawn | No outcome recorded |
| Phase 2 | NCT03036384 Background | Mar → Nov 2016 | — | Centre Hospitalier Universitaire Saint Pierre | Completed | No outcome recorded |
| Phase 2 | NCT02232347 Comparator | Oct 2014 → Oct 2016 | traumatic brain injury | Pierre-Julien CUNGI | Unknown | No outcome recorded |
| Phase 2 | NCT02036736 Background | Apr 2013 → Dec 2014 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 2 | NCT01572116 Comparator | Jan 2010 → Jun 2011 | pulpitis | Islamic Azad University, Sanandaj | Completed | No outcome recorded |
| Phase 2 | NCT00894699 Comparator | Jun → Sep 2009 | anxiety | Talphera, Inc | Completed | No outcome recorded |
| Phase 2/36 trials | ||||||
| Phase 2/3 | NCT05508594 Comparator | Sep 2022 → Oct 2023 | — | Cessatech A/S | Completed | No outcome recorded |
| Phase 2/3 | NCT05446623 Comparator | Jan 2021 → Oct 2024 | arthropathy | Centre Hospitalier de Montauban | Completed | No outcome recorded |
| Phase 2/3 | NCT04021264 Comparator | Aug 2019 → Jan 2022 | intestinal disorder, liver disorder, pancreas disorder | University of Alberta | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT02700893 Comparator | Mar → Aug 2016 | cerebrovascular disorder | Centre Hospitalier Intercommunal Creteil | Completed | No outcome recorded |
| Phase 2/3 | NCT01490580 Comparator | May 2012 → Aug 2016 | — | Centre Hospitalier Intercommunal Creteil | Completed | No outcome recorded |
| Phase 2/3 | NCT01406678 Comparator | Jul 2008 → Mar 2018 | myocardial infarction | University Hospital, Essen | Completed | No outcome recorded |
| Phase 315 trials | ||||||
| Phase 3 | NCT07414706 Background | Mar 2026 → Jun 2028 expected | local anesthetic poisoning | Centre Hospitalier Universitaire, Amiens | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07166991 Comparator | Feb 2026 → Sep 2028 expected | — | University Hospital, Grenoble | Recruiting | No outcome recorded |
| Phase 3 | NCT05831345 Comparator | Feb 2023 → Dec 2025 overdue | — | Brugmann University Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT05072704 Comparator | Feb 2022 → Feb 2023 | — | CMC Ambroise Paré | Completed | No outcome recorded |
| Phase 3 | NCT04797312 Comparator | Jul 2021 → Nov 2022 | local anesthetic poisoning | University Hospital, Angers | Unknown | No outcome recorded |
| Phase 3 | NCT04144933 Comparator | May 2021 → Jul 2024 | paralytic ileus | University of Saskatchewan | Unknown | No outcome recorded |
| Phase 3 | NCT03825198 Comparator | Aug 2019 → Dec 2023 | neuropathy, painful, peripheral nerve lesion | Dr M. B. Breebaart | Unknown | No outcome recorded |
| Phase 3 | NCT03117023 Background | Apr → May 2017 | gastric cancer | Nanjing PLA General Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02857465 Background | Jan → Jun 2017 | neonatal compartment syndrome, obstetric disorder | Centre Hospitalier Universitaire de la Réunion | Withdrawn | No outcome recorded |
| Phase 3 | NCT02752477 Comparator | Aug 2016 → Sep 2020 | chronic pain syndrome | Ben Lim | Unknown | No outcome recorded |
| Phase 3 | NCT02597699 Comparator | Dec 2015 → Mar 2019 | — | University Hospital, Montpellier | Completed | No outcome recorded |
| Phase 3 | NCT02563821 Comparator | Nov 2015 → Dec 2018 | — | University Hospital, Limoges | Completed | No outcome recorded |
| Phase 3 | NCT01235637 Comparator | Jun 2010 → Jun 2012 | — | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 3 | NCT01858090 Comparator | Jan → Oct 2009 | — | Baskent University | Completed | No outcome recorded |
| Phase 3 | NCT00437996 Background | Feb 2007 → Jan 2008 | — | Hospices Civils de Lyon | Completed | No outcome recorded |
| Phase 477 trials | ||||||
| Phase 4 | NCT07659132 Background | Jun → Sep 2026 expected | urolithiasis | Shiyou Wei | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07660380 Comparator | Jun → Jul 2026 overdue | — | Shiyou Wei | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07637968 Comparator | Jun 2026 → Jan 2027 expected | — | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07576517 Background | Jun 2026 → Jun 2029 expected | cognitive disorder | Peking University First Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07334132 Background | Apr 2026 → Dec 2029 expected | osteoarthritis | Region Örebro County | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07523321 Background | Apr 2026 → Apr 2027 expected | — | Peking University First Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07525999 Background | Apr 2026 → Nov 2027 expected | — | Peking University First Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07377630 Background | Mar 2026 → Mar 2027 expected | pregnancy disorder | Gaslini Institute | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07018375 Comparator | Jan 2026 → Mar 2027 expected | chronic pain syndrome | Tianjin Medical University General Hospital | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT07235995 Comparator | Dec 2025 → Jan 2027 expected | delirium | Xiangya Hospital of Central South University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07019818 Comparator | Oct 2025 → Jan 2028 expected | — | University Hospital, Limoges | Recruiting | No outcome recorded |
| Phase 4 | NCT07406555 Comparator | Oct 2025 | traumatic brain injury | Universitas Jenderal Soedirman | Completed | No outcome recorded |
| Phase 4 | NCT07145775 Comparator | Sep 2025 → Jan 2026 | — | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT06530563 Comparator | Aug 2025 → Apr 2026 overdue | — | Xiangya Hospital of Central South University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06958393 Comparator | May 2025 → Jan 2026 overdue | subacute delirium | Qianfoshan Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06859892 Background | Mar 2025 → Nov 2026 expected | sleep disorder | Peking University First Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07456111 Background | Jan 2025 → Nov 2027 expected | polyp of colon | Clinical Hospital Centre Zagreb | Recruiting | No outcome recorded |
| Phase 4 | NCT06566482 Background | Sep 2024 → Sep 2025 overdue | obstructive sleep apnea syndrome | Peking University First Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT06145165 Background | Dec 2023 → Dec 2024 | — | Nanjing First Hospital, Nanjing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT06037330 Comparator | Sep 2023 → Apr 2026 overdue | acute respiratory distress syndrome | Hairong Chen | Recruiting | No outcome recorded |
| Phase 4 | NCT06041425 Comparator | Aug → Dec 2023 | hepatocellular carcinoma | The First Affiliated Hospital with Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT05826327 Comparator | May 2023 → Jun 2025 | postpartum depression | Women's Hospital School Of Medicine Zhejiang University | Unknown | No outcome recorded |
| Phase 4 | NCT05698407 Comparator | Mar → Jun 2023 | pregnancy disorder | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05750056 Background | Feb 2023 → Mar 2024 | — | Fujian Provincial Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05718544 Background | Jan → Sep 2023 | chronic pain syndrome, scoliosis | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05670561 Comparator | Jan → Jun 2023 | hepatocellular carcinoma | The Second Affiliated Hospital of Chongqing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT05624424 Background | Nov 2022 → Oct 2023 | — | Second Affiliated Hospital of Nanchang University | Unknown | No outcome recorded |
| Phase 4 | NCT05416073 Comparator | Jun 2022 → Apr 2023 | hepatocellular carcinoma | The Second Affiliated Hospital of Chongqing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT05299866 Background | Apr 2022 → May 2024 | — | Ling Dong | Unknown | No outcome recorded |
| Phase 4 | NCT05307341 Comparator | Mar 2022 → Jun 2023 | — | More Foundation | Unknown | No outcome recorded |
| Phase 4 | NCT05229913 Background | Feb → Sep 2022 | postpartum depression | Qinghai University | Unknown | No outcome recorded |
| Phase 4 | NCT06232785 Comparator | Feb 2022 → Oct 2023 | motion sickness | Second Hospital of Jilin University | Completed | No outcome recorded |
| Phase 4 | NCT04791059 Background | Apr 2021 → Sep 2022 | scoliosis | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04755712 Background | Mar 2021 → Oct 2022 | — | Ramsay Santé | Completed | No outcome recorded |
| Phase 4 | NCT04561375 Comparator | Dec 2020 → Jul 2022 | — | The Cleveland Clinic | Terminated | No outcome recorded |
| Phase 4 | NCT04464512 Comparator | Jan 2020 → Aug 2021 | chronic pain syndrome, disease of bone structure, opiate dependence | West Virginia University | Withdrawn | No outcome recorded |
| Phase 4 | NCT04248179 Comparator | Nov 2019 → Dec 2021 | ductal breast carcinoma in situ | Zealand University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03849508 Background | Feb 2019 → Dec 2020 | — | Centre Hospitalier Régional d'Orléans | Completed | No outcome recorded |
| Phase 4 | NCT03685188 Comparator | Dec 2018 → Dec 2024 overdue | — | West China Hospital | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT03726268 Comparator | Nov 2018 → Jul 2023 | substance-related disorder | Duke University | Completed | No outcome recorded |
| Phase 4 | NCT03629262 Background | Oct 2018 → Dec 2019 | delirium | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03395600 Comparator | Feb → Aug 2018 | — | Fudan University | Completed | No outcome recorded |
| Phase 4 | NCT03344042 Comparator | Dec 2017 → Dec 2018 | — | Medical University of Warsaw | Unknown | No outcome recorded |
| Phase 4 | NCT02989597 Background | Jul 2017 → Nov 2020 | — | Montefiore Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT03152955 Background | May 2017 → May 2018 | trigeminal neuralgia | Xiangya Hospital of Central South University | Unknown | No outcome recorded |
| Phase 4 | NCT03007121 Comparator | Apr 2017 → Dec 2018 | — | Charles University, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT03018171 Comparator | Jan → Jun 2017 | — | San Giovanni Calibita Fatebenefratelli Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02923128 Comparator | Nov 2016 → Oct 2020 | delirium, subjective cognitive decline | Zhejiang Cancer Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02885350 Comparator | Sep 2016 → May 2018 | — | Helsinki University Central Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02727712 Background | Apr → Sep 2016 | coronary artery disorder | Xiangya Hospital of Central South University | Unknown | No outcome recorded |
| Phase 4 | NCT02816567 Background | Jan 2016 → Jan 2018 | — | Reims University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02644980 Background | Dec 2015 → Aug 2016 | delirium | Xijing Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02741219 Comparator | Nov 2015 → Jan 2016 | — | Obstetrics & Gynecology Hospital of Fudan University | Completed | No outcome recorded |
| Phase 4 | NCT02573597 Comparator | Oct 2015 → May 2018 | pregnancy disorder | Stanford University | Terminated | No outcome recorded |
| Phase 4 | NCT02552459 Background | Sep 2015 → Dec 2016 | arteriovenous hemangioma/malformation | First Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
| Phase 4 | NCT02712528 Comparator | May 2015 → Dec 2016 | cardiac valvular defect | Konkuk University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT02756598 Comparator | Jan 2015 → Jan 2018 | postoperative ventricular dysfunction | Aarhus University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02147678 Background | Dec 2014 → Feb 2015 | — | Shaanxi Provincial People's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02123355 Background | Aug 2014 | CGF1, brain injury | Shaanxi Provincial People's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02213718 Background | Jul 2014 → Jan 2017 | coronary restenosis, local anesthetic poisoning | Huazhong University of Science and Technology | Unknown | No outcome recorded |
| Phase 4 | NCT02134093 Background | Jul 2014 → May 2015 | — | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02085577 Background | May 2014 → Oct 2015 | chronic pain syndrome | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT02154074 Background | May → Oct 2014 | post-surgical hypoinsulinemia | Second Affiliated Hospital of Xi'an Jiaotong University | Unknown | No outcome recorded |
| Phase 4 | NCT02111265 Background | Apr → Jul 2014 | adrenocortical insufficiency | Second Affiliated Hospital of Xi'an Jiaotong University | Unknown | No outcome recorded |
| Phase 4 | NCT02544282 Comparator | Apr 2014 → Mar 2016 | — | GZA Ziekenhuizen Campus Sint-Augustinus | Completed | No outcome recorded |
| Phase 4 | NCT02036242 Comparator | Sep 2013 → Feb 2014 | — | Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT01910285 Comparator | Jun 2013 → Sep 2015 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 4 | NCT02152514 Comparator | Apr 2013 → May 2015 | — | University of Sherbrooke | Terminated | No outcome recorded |
| Phase 4 | NCT01516268 Comparator | Jan 2012 → Feb 2013 | — | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02677532 Comparator | Dec 2011 → Nov 2013 | — | University of Genova | Completed | No outcome recorded |
| Phase 4 | NCT01490268 Comparator | Nov 2011 → Sep 2012 | — | University of Erlangen-Nürnberg Medical School | Completed | No outcome recorded |
| Phase 4 | NCT02053818 Comparator | Aug 2011 → Jun 2015 | aortic valve stenosis, myocardial ischemia | Aarhus University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01320475 Comparator | Sep 2010 → Jul 2011 | — | Hopital Foch | Terminated | No outcome recorded |
| Phase 4 | NCT00772616 Comparator | Sep 2008 → Jan 2010 | — | Hopital Foch | Completed | No outcome recorded |
| Phase 4 | NCT00738192 Comparator | Jul 2008 → Mar 2009 | — | Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT00929682 Background | Jun 2007 → Mar 2008 | — | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| Phase 4 | NCT01229241 Background | Jul 2005 → Jun 2011 | — | Fondazione IRCCS Policlinico San Matteo di Pavia | Completed | No outcome recorded |
| Phase not applicable79 trials | ||||||
| — | NCT07702240 Comparator | Jul 2026 → Mar 2028 expected | biliary tract disorder | Ren Da | Not yet recruiting | No outcome recorded |
| — | NCT07584902 Comparator | Apr → Oct 2026 expected | hepatobiliary disorder | Gang Chen | Not yet recruiting | No outcome recorded |
| — | NCT07479446 Comparator | Mar 2026 → Aug 2027 expected | cerebellopontine angle tumor | Xuanwu Hospital, Beijing | Recruiting | No outcome recorded |
| — | NCT07386626 Comparator | Mar → Dec 2026 expected | — | Tongji Hospital | Recruiting | No outcome recorded |
| — | NCT07323043 Comparator | Jan → Aug 2026 overdue | local anesthetic poisoning | The First People's Hospital of Lianyungang | Recruiting | No outcome recorded |
| — | NCT07307495 Comparator | Jan 2026 → Jul 2027 expected | — | Xijing Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07376577 Comparator | Jan 2026 → Mar 2028 expected | — | The First Affiliated Hospital of Xinxiang Medical College | Not yet recruiting | No outcome recorded |
| — | NCT07204106 Background | Oct → Nov 2025 | — | Shiyou Wei | Completed | No outcome recorded |
| — | NCT07372209 Comparator | Oct → Dec 2025 | — | Tangshan Maternal and Child Health Hospital | Completed | No outcome recorded |
| — | NCT07187765 Comparator | Sep → Nov 2025 | — | Shiyou Wei | Completed | No outcome recorded |
| — | NCT07192549 Background | Sep 2025 → Sep 2030 expected | delirium | General Hospital of Ningxia Medical University | Not yet recruiting | No outcome recorded |
| — | NCT07713134 Comparator | Aug 2025 → May 2026 | — | Tangshan Maternal and Child Health Hospital | Completed | No outcome recorded |
| — | NCT07084753 Comparator | Jul → Sep 2025 overdue | obesity disorder | IVO JURISIC | Not yet recruiting | No outcome recorded |
| — | NCT07092384 Comparator | Jul → Nov 2025 | — | Tongji Hospital | Completed | No outcome recorded |
| — | NCT06990763 Background | Jun → Dec 2025 overdue | female reproductive system disorder | Second Hospital of Shanxi Medical University | Not yet recruiting | No outcome recorded |
| — | NCT07244822 Comparator | Jun → Jul 2025 | traumatic brain injury | Universitas Jenderal Soedirman | Completed | No outcome recorded |
| — | NCT06900205 Background | Apr 2025 → Mar 2026 | delirium, sleep disorder | RenJi Hospital | Withdrawn | No outcome recorded |
| — | NCT06775366 Background | Feb 2025 → Apr 2026 overdue | circadian rhythm sleep disorder, cognitive disorder | The Second Affiliated Hospital of Chongqing Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06817239 Background | Feb 2025 → Jun 2027 expected | delirium | Nanfang Hospital, Southern Medical University | Recruiting | No outcome recorded |
| — | NCT06795594 Background | Jan → Mar 2025 | — | Beijing Tongren Hospital | Completed | No outcome recorded |
| — | NCT06607029 Comparator | Oct 2024 → Dec 2025 overdue | supratentorial cancer | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT06367218 Background | Oct 2024 → Jul 2026 overdue | — | Tongji Hospital | Recruiting | No outcome recorded |
| — | NCT06493396 Comparator | Aug 2024 → Aug 2025 overdue | sleep disorder | Beijing Friendship Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06305221 Comparator | Mar 2024 → Mar 2025 | postgastrectomy syndrome | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT06310785 Comparator | Feb → Oct 2024 | — | Hui Xu | Completed | No outcome recorded |
| — | NCT06199011 Comparator | Jan 2024 → Oct 2025 | depressive disorder | The Second Hospital of Anhui Medical University | Unknown | No outcome recorded |
| — | NCT06172140 Background | Jan → Apr 2024 | — | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Completed | No outcome recorded |
| — | NCT06155903 Comparator | Dec 2023 → Apr 2024 | — | Federico II University | Completed | No outcome recorded |
| — | NCT05731973 Comparator | Dec 2023 → Apr 2025 | pectus excavatum | Zuyderland Medical Center | Completed | No outcome recorded |
| — | NCT06120439 Background | Dec 2023 → May 2024 | breast cancer | Jun Zhang | Completed | No outcome recorded |
| — | NCT06382961 Comparator | Nov 2023 → Mar 2024 | delirium | Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. | Completed | No outcome recorded |
| — | NCT06082856 Comparator | Oct 2023 → Feb 2026 overdue | — | Nîmes University Hospital | Recruiting | No outcome recorded |
| — | NCT05960942 Comparator | Aug → Oct 2023 | autism spectrum disorder | The Second Hospital of Nanjing Medical University | Completed | No outcome recorded |
| — | NCT07064408 Background | Jun 2023 → Nov 2024 | — | Hebei Medical University Fourth Hospital | Completed | No outcome recorded |
| — | NCT07083440 Background | Jun 2023 → May 2024 | digestive system disorder | Children's Hospital of Hebei Province | Completed | No outcome recorded |
| — | NCT06778460 Background | May 2023 → Mar 2027 expected | chronic pain syndrome | West China Hospital | Recruiting | No outcome recorded |
| — | NCT05550714 Background | Oct 2022 → Mar 2024 overdue | Parkinson disease | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT05548465 Comparator | Sep 2022 → Oct 2023 | — | West China Hospital | Completed | No outcome recorded |
| — | NCT05423951 Background | Jul 2022 → Nov 2023 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT05242081 Comparator | Jul → Dec 2022 | substance-related disorder | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
| — | NCT05815056 Comparator | Mar → Aug 2022 | — | Centre Hospitalier Regional de Huy | Completed | No outcome recorded |
| — | NCT05042817 Comparator | Oct 2021 → Mar 2022 | — | University of Liege | Completed | No outcome recorded |
| — | NCT04924621 Comparator | Jun 2021 → May 2022 | substance withdrawal syndrome | Peking University | Unknown | No outcome recorded |
| — | NCT04213781 Background | Sep → Nov 2020 | — | CMC Ambroise Paré | Completed | No outcome recorded |
| — | NCT05249153 Background | Sep 2020 → Dec 2025 | — | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT04507165 Comparator | Aug 2020 → Jul 2021 | — | Peking University People's Hospital | Unknown | No outcome recorded |
| — | NCT03864276 Background | Feb 2019 → Dec 2020 | cirrhosis of liver | Yonsei University | Completed | No outcome recorded |
| — | NCT03830086 Background | Feb → Apr 2019 | — | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Completed | No outcome recorded |
| — | NCT03677323 Comparator | Jan → Feb 2019 | toe, misshapen | Clinique Saint Jean, France | Completed | No outcome recorded |
| — | NCT03682354 Comparator | Sep 2018 → Mar 2019 | lung disorder | Peking University Third Hospital | Completed | No outcome recorded |
| — | NCT03738137 Background | Aug 2018 → Jan 2019 | — | Guangzhou Institute of Respiratory Disease | Completed | No outcome recorded |
| — | NCT03245346 Background | Dec 2017 → Jun 2023 | malignant pancreatic neoplasm | Fudan University | Completed | No outcome recorded |
| — | NCT02910206 Background | Aug 2017 → Nov 2019 | — | Zhihong LU | Completed | No outcome recorded |
| — | NCT03219086 Comparator | Aug 2017 → May 2022 | — | University Hospital, Antwerp | Completed | No outcome recorded |
| — | NCT02666794 Comparator | Jul 2017 → Oct 2020 | uterine disorder | University of Sao Paulo General Hospital | Completed | No outcome recorded |
| — | NCT03129009 Comparator | Apr 2017 → Jun 2018 | intracerebral hemorrhage | Xuzhou Medical University | Unknown | No outcome recorded |
| — | NCT03096730 Comparator | Feb → Dec 2017 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
| — | NCT02873091 Comparator | Sep 2016 → May 2017 | — | Nanjing Maternity and Child Health Care Hospital | Unknown | No outcome recorded |
| — | NCT02625181 Background | Jul 2016 → Nov 2017 | — | Vanderbilt University | Completed | No outcome recorded |
| — | NCT02711072 Background | Mar 2016 | — | Tunisian Military Hospital | Unknown | No outcome recorded |
| — | NCT03470363 Comparator | Jan 2016 → Mar 2018 | — | University of Liege | Completed | No outcome recorded |
| — | NCT02647047 Comparator | Jan → Nov 2016 | hepatobiliary neoplasm, liver disorder, secondary malignant neoplasm | Ospedale San Raffaele | Unknown | No outcome recorded |
| — | NCT02400879 Comparator | Oct 2015 | cardiovascular disorder | Konkuk University Medical Center | Completed | No outcome recorded |
| — | NCT02385539 Comparator | Jan → Sep 2015 | — | Šarić, Jadranka Pavičić, M.D. | Completed | No outcome recorded |
| — | NCT03012945 Background | Nov 2014 → Sep 2019 | cancer | Peking University First Hospital | Completed | No outcome recorded |
| — | NCT02043366 Comparator | Feb 2014 → Jun 2015 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
| — | NCT03185403 Comparator | Dec 2013 → Jul 2016 | esophageal cancer | University Hospital, Lille | Completed | No outcome recorded |
| — | NCT01871935 Comparator | Jun → Oct 2013 | — | University Medical Center Groningen | Unknown | No outcome recorded |
| — | NCT01489631 Comparator | Mar 2013 → Apr 2014 | — | St. Antonius Hospital | Completed | No outcome recorded |
| — | NCT01785446 Comparator | Nov 2012 → Feb 2013 | — | Tianjin Medical University General Hospital | Unknown | No outcome recorded |
| — | NCT01860521 Comparator | Sep 2011 → Jun 2013 | — | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Completed | No outcome recorded |
| — | NCT01608334 Comparator | Aug 2011 → Jan 2012 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02794584 Comparator | Jan 2011 → Dec 2016 | ventricular septal defect | Nanjing Medical University | Completed | No outcome recorded |
| — | NCT01759706 Background | Oct 2010 → Dec 2012 | pancreatic neoplasm | Vita-Salute San Raffaele University | Completed | No outcome recorded |
| — | NCT01248871 Comparator | Sep 2010 → Oct 2012 | — | University Medical Center Groningen | Completed | No outcome recorded |
| — | NCT00987441 Comparator | Sep 2009 → Jul 2011 | — | Nanjing Medical University | Completed | No outcome recorded |
| — | NCT01525537 Comparator | Mar 2009 → Feb 2010 | — | University Hospital Schleswig-Holstein | Completed | No outcome recorded |
| — | NCT01261689 Comparator | Sep 2008 → Nov 2013 | — | Maastricht University Medical Center | Completed | No outcome recorded |
| — | NCT02499445 Comparator | Nov 2007 → Oct 2014 | ischemic disease | Konkuk University Medical Center | Completed | No outcome recorded |
Evidence & citations 27 cited values
Every value below carries the sentence it was read from. 305 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sufentanil | “After surgery, patient-controlled intravenous analgesia will be established with dexmedetomidine (DEX 1.5 ug/ml), esketamine (ESK 0.5 mg/ml), and sufentanil (1.25 ug/ml),...” NCT07523321 ↗288“Postoperative patient-controlled analgesia will be established with a 100 mL mixture (containing 1.0 μg/mL sufentanil, 1.25 μg/mL dexmedetomidine, and 0.25 mg/mL esketamine in...” NCT07576517 ↗ “The parturients were randomly assigned to groups receiving either spinal sufentanil (5 µg), epidural sufentanil (20 µg), spinal fentanyl (20 µg) or epidural fentanyl (100 µg),...” PMID 31286476 ↗ Jul 2019 “Epidural block is widely used as an analgesic method during labor. During epidural anaesthesia, lipophilic opioids such as sufentanil, are often combined with local anesthetics...” NCT03395600 ↗ “The study solutions were either 0.568 mg x ml(-1) levobupivacaine (low concentration group) or 1.136 mg x ml(-1) levobupivacaine (high concentration group), with sufentanil...” PMID 20565392 ↗ Jun 2010 “The aim of this study was to compare the recovery of 2 Bispectral index (BIS)-guided anesthesia protocols combining sevoflurane-sufentanil (SS) or propofol-remifentanil (PR)...” PMID 23774117 ↗ Jan 2014 “Open-label, Prospective Study to Assess the Safety, Tolerability, Analgesic Effect and Feasibility of Intranasal Sufentanil/Ketamine in Pediatric Patients With Moderate or...” NCT06364072 ↗ “Sufentanil, unlike morphine and hydromorphone, avoids the issue of active metabolites that can lead to prolonged, untoward effects, which can complicate postoperative care and...” NCT04263909 ↗ “This typically involves the intravenous (IV) administration of strong opioids such as Fentanyl or Sufentanil to manage the intense pain during the craniotomy (bone flap...” NCT07510217 ↗ “Remimazolam 6mg/kg/h was pumped intravenously for 2.5 min, Sufentanil 0.5 μg/kg and rocuronium 0.6mg/kg were injected intravenously, and endotracheal intubation was performed 3...” NCT06775366 ↗ “Postoperative analgesia was provided by patient-controlled intravenous sufentanil, supplemented by randomly assigned dexmedetomidine (1.25 μg/mL) or placebo, for up to three days.” PMID 34517840 ↗ Sep 2021 “Total intravenous anesthesia induced with sufentanil,etomidate,cisatracurium and midazolam and maintained with propofol,cisatracurium and remifentanil target controlled infusion” NCT03129009 ↗ “Patients were randomized to receive an epidural infusion of levobupivacaine 0.125% + sufentanil 0.75 μg/mL or of ropivacaine 0.2% + sufentanil 0.75 μg/mL at 5 mL/h for 48 hours.” PMID 25977992 ↗ Aug 2015 “After surgery, patient-controlled intravenous analgesia will be established with dexmedetomidine (DEX 1.5 ug/ml), esketamine (ESK 0.5 mg/ml), and sufentanil (1.25 ug/ml)” NCT07525999 ↗ “General anesthesia will be maintained with inhalation (sevoflurane) and sufentanil infusion, and muscle relaxants will be administered when considered necessary.” NCT03245346 ↗ “Patients were randomized to receive sufentanil 0.05ug/kh/h + dexmedetomidine 0.1ug/kg/h (DEX group) or sufentanil 0.05ug/kg/h + saline (control group) for 48h.” NCT03117023 ↗ “Patient-controlled analgesia is established with dexmedetomidine (1 μg/ml), esketamine (1 mg/ml), and sufentanil (1 μg/ml) in a total volume of 100 ml.” NCT06566482 ↗ “general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg” NCT02154074 ↗ “Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery” NCT06439368 ↗ “Optional intrathecal opioid adjuncts, with fentanyl or sufentanil, may be used to enhance analgesia according to routine clinical practice.” NCT07334132 ↗ “Patients used the Zalviso™ (sufentanil sublingual tablet system) 15 mcg to self-administer a tablet of study drug as needed for pain.” NCT02662764 ↗ “The pump is established with S-ketamine 1mg/kg, sufentanil 2microgram/kg, andondansetron16mg, diluted with normal saline to 100 ml.” NCT05299866 ↗ “Intravenous injection of 0.1ug/kg sufentanil and 0.03mg/kg midazolam for sedation and analgesia before radial artery cannulation” NCT05863455 ↗ “Remimazolam, sufentanil and rocuronium were used during induction, and remimazolam and refentanil were used during maintenance” NCT06990763 ↗ “were given sufentanil citrate 0.1-0.2 µg/kg, cisatracurium 0.2 mg/kg and propofol 1.5-2.0 mg/kg during anesthesia induction.” NCT05550714 ↗ “Patient-controlled intravenous analgesia is established with 100 μg dexmedetomidine, 50 mg esketamine, and 100 μg sufentanil” NCT06859892 ↗ “all patients receive spinal anesthesia with a solution of 2 ml hyper-baric bupivacaine 0.5% (10 mg) and 3 μg of sufentanil” NCT07377630 ↗ “It will consist of the following local anesthetics and adjuvants: Hypobaric Bupivacaine 0.5% 7.5 mg and Sufentanil 5 µg.” NCT06155903 ↗ “Sufentanil 0.5 mg/L is used as solution for injection for epidural analgesia and used in combination with ropivacaine.” NCT02857465 ↗ “Single- and Multiple-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab® PCA System (Zalviso™) in Healthy Subjects” NCT01761565 ↗ “Postoperative intravenous analgesia pump formula：Esketamine 0.2mg/kg + Sufentanil 1ug/kg+ Flurbiprofen Axetil 200mg.” NCT05229913 ↗ “In the opioid anesthetic group, intravenous sufentanil will be administrated during the organ procurement procedure.” NCT07166991 ↗ “Effect of Equivalent Dose of Alfentanil and Sufentanil Combined With Remimazolam in Complex Bronchoscopic Treatment” NCT06414018 ↗ “Rescue opioids will be given as sufentanil 5μg/hr, depending on the time of the last intraoperative administration.” NCT06015165 ↗ “Intraoperative analgesia will be administered with conventional opioid drugs such as sufentanil and remifentanil.” NCT06607029 ↗ “For all patients, the induction protocol is midazolam 0.1 mg/kg, sufentanil 0.3 μg/kg, cisatracurium 0.15 mg/kg.” NCT02147678 ↗ “Another PCIA device contained sufentanil 2 ug/kg, granisetron 12 mg diluted to 200 mL in 0.9 % normal saline.” NCT06778460 ↗ “Intra-operatively: Bupivacaine 0.5% with adrenaline Post-operatively: Ropivacaine 0.2% + sufentanil 1 ug” NCT01367418 ↗ “a formulation consisting of esketamine 50mg and sufentanil 200 μg, diluted to a total volume of 200 ml.” NCT06817239 ↗ “Anesthesia was induced by sequential intravenous injection of remimazolam, sufentanil, and rocuronium.” NCT07192549 ↗ “During the operation, both the induction and maintenance of anesthesia were achieved using sufentanil.” NCT07650812 ↗ “Both 2.5 µg sufentanil and 100 µg morphine were added to the local anaesthetic agent in both groups.” PMID 33428221 ↗ Jan 2021 “Sufentanil intravenous (0.1 in 0.2 µg / kg) and propofol (5 in 10 mg / kg on 3 mn) administration” NCT02505880 ↗ “Anesthesia was induced by intravenous injection of Sufentanil 0.1 µg/kg and propofol 2 mg /kg.” NCT06367218 ↗ “All patients received 5 μ g of sufentanil 1 minute before intravenous infusion of ciprofol” NCT06172140 ↗ “Traditional general anesthetic technique utilizing sufentanil, fentanyl or remifentanil” NCT02752477 ↗ “Induction use Sufentanil 0.5\~1ug/kg, Vecuronium for Injection 0.15mg/kg and Etomidate” NCT02727712 ↗ “General anesthesia induction will be induced performed with sufentanil (0.5 μg kg-1)” NCT06199011 ↗ “Drug: Sufentanil will be injected in the subarachnoid space with a dose of 2,5μg” NCT03849508 ↗ “Patient-controlled intravenous analgesia regimen is conducted with sufentanil.” NCT03682354 ↗ “Epidural analgesia is performed with a mixture of ropivacaine and sufentanil.” NCT03012945 ↗ “sublingual sufentanil (Dsuvia) will improve postoperative pain management” NCT04716413 ↗ “5, 7 mcg of Sufentanil (Sufenta, Janssen-Pharmaceutica, amp. 5 mcg/ml)” NCT02385539 ↗ “sufentanil was administered for analgesia in primary cesarean section” NCT02595333 ↗ “Anesthesia is induced and maintained with desflurane and sufentanil” NCT03864276 ↗ “the PCIA pump equipped with sufentanil injection will be connected” NCT06145165 ↗ “Spinal anesthesia with bupivacaine 12.5 mg+sufentanil 5 ug” NCT03639389 ↗ “Sufentanil 0.5 mcg/kg + ketamine 0.5 mg/kg as nasal spray” NCT04897750 ↗ “Individualized analgesia with sufentanil and ropivacaine” NCT02920489 ↗ “Sufentanil: Fentatienil®, Angelini, Rome, Italy.” NCT01860521 ↗ “Sufentanil (0.15 mg / kg intravenously (IV))” NCT02036736 ↗ “0.5 μ g / ml sufentanil+ 0.1 % ropivacaine” NCT03622047 ↗ “sufentanil 0.3μg/kg (intravenous bolus)” NCT04507165 ↗ “Propofol 2 mg/kg; Sufentanil 0.2 µg/kg” NCT07414706 ↗ “mixture of bupivacaine and sufentanil” NCT04755712 ↗ “Sufentanil is used after surgery” NCT06658990 ↗ “0.3-0.5 μg/kg sufentanil” NCT07603596 ↗ “sufentanil 0.3μg/kg iv” NCT06120439 ↗ |
| Known as | ARX-F01 | “A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing...” NCT00718081 ↗1“the ARX-F01 pain medication (Sufentanil NanoTab 15 mcg) for the treatment of post-operative pain” NCT00859313 ↗ |
| Known as | Brand name:Sufenta | “Brand name:Sufenta” NCT01572116 ↗ |
| Known as | DSUVIA | “Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in...” NCT05288348 ↗1“sublingual sufentanil (Dsuvia) will improve postoperative pain management” NCT04716413 ↗ |
| Known as | Dzuveo | “including sublingual sufentanil (Dzuveo®, 30 µg), which combines opioid-like effects with a faster onset of action due to its lipophilicity.” NCT07624006 ↗ |
| Known as | IDS-NS-001 | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | R 33800 | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | R30730 | “Sufentanil (R30730, brand name Sufenta)” NCT01917045 ↗ |
| Known as | Sufenta | “Sufentanil (R30730, brand name Sufenta)” NCT01917045 ↗ |
| Known as | Sufenta preservative free | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | Sufental | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | sufentanil (DSUVIA) | “sufentanil (DSUVIA)” NCT05307341 ↗ |
| Known as | Sufentanil = Sufenta | “Sufentanil = Sufenta” NCT01367418 ↗ |
| Known as | Sufentanil Citrate | “Sufentanil Citrate injection, specification: 50 ug/ml, 1 ml; Avoid light seal; Yichang humanwell pharmaceutical co., LTD.” NCT06530563 ↗ |
| Known as | Sufentanil citrate cii | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | sufentanil injection | “Drug: Sufentanil Injection” NCT04067648 ↗1“sufentanil injection” NCT06530563 ↗ |
| Known as | Sufentanil NanoTab | “the ARX-F01 pain medication (Sufentanil NanoTab 15 mcg) for the treatment of post-operative pain” NCT00859313 ↗1“Sufentanil NanoTab 20 mcg as needed every 60 minutes for 12 hours” NCT01710345 ↗ |
| Known as | Sufentanil, Sufenta, (R-30730) | “Sufentanil, Sufenta, (R-30730)” NCT01406678 ↗ |
| Known as | Sufentanil: Fentatienil, Angelini, Rome, Italy. | “Sufentanil: Fentatienil®, Angelini, Rome, Italy.” NCT01860521 ↗ |
| Known as | Sufentanilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL658 ↗ |
| Known as | sufentanyl | “Midazolam 0.03 mg/kg injection vein，Sufentanyl 0.5\~1 μg/kg, target controlled infusion of etomidate or propofol,after the consciousness of patients is lost, rocuronium...” NCT02644980 ↗12“A combined spinal epidural anesthesia with spinal administration of 50 mg hyperbaric prilocaine 2% (Tachipri, Nordic Pharma) + 2,5mcg sufentanyl (5 mcg/ml) (Janssens-cilag)” NCT03219086 ↗ “Midazolam 0.05 mg/kg、Propofol 1.0 mg/kg、Sufentanyl 3μg/kg、Victracurium 0.1 mg/kg sequential intravenous injection” NCT02123355 ↗ “The patient will receive the intravenous opioid analgesic sufentanyl 0.2 mcg/kg over a period of 30 seconds.” NCT07456111 ↗ “spinal anesthesia with 10 mg hyperbaric Bupivacaïne 0,5% + 2,5 µ Sufentanyl + 100 µ of intrathecal Morphine” NCT02711072 ↗ “propofol 2mg kg-1, sufentanyl 0.3-0.5 μ g kg-1, rocuronium” NCT06493396 ↗ “using sufentanyl 5mg intravenously during the surgery” NCT05815056 ↗ |
| Known as | Zalviso | “Patients used the Zalviso™ (sufentanil sublingual tablet system) 15 mcg to self-administer a tablet of study drug as needed for pain.” NCT02662764 ↗ |
| Known as | Zalviso (sufentanil sublingual tablet system) 15 mcg | “Zalviso™ (sufentanil sublingual tablet system) 15 mcg” NCT02662764 ↗ |
| Action | Activate | “Mu opioid receptor agonist” CHEMBL658 ↗1“a pure μ receptor agonist” NCT03685188 ↗ |
| Modality | Other / unclassified | “Sufentanil (medium/long acting opioid)” NCT02053818 ↗ |
| Route | Other | “The addition of clonidine to epidural levobupivacaine and sufentanil for patient-controlled epidural analgesia in labour improved analgesia, reduced the supplementation rate...” PMID 20299988 ↗ May 2010 |
| Target | OPRM1 | “Mu opioid receptor agonist” CHEMBL658 ↗ |